SHORT ORAL PRESENTATION 7 - 4I 2
Tracks
TIRANA
| Thursday, October 23, 2025 |
| 1:45 PM - 2:45 PM |
Details
Tirana Room
Moderators: Claus Klingenberg, Norway, Varvara Dimopoulou, Switzerland
304
Hexavalent vaccination in preterm infants: Deviations from the recommended 3+1 vaccination schedule in one year old very preterm infants
Michael Zemlin, Germany
113
Neonatal methylation-based predictors of cognition at 2 and 5 years of age
Rebekah Smikle, United Kingdom
347
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Breastfeeding: The Prospective, Multicentre, Open-Label, Phase IV SOPRANINO Study
Carlo Pietrasanta, Italy
656
A NOVEL ASSOCIATION BETWEEN MATERNAL HLA/HNA ANTIBODIES AND NEONATAL RESPIRATORY DISTRESS
Kajsa Bohlin, Sweden
94
Emergence of Carbapenem-Resistant Enterobacteriaceae (CPE) and Other Multidrug-Resistant Gram-Negative Bacteria in Neonates at a Tertiary-Level NICU in Tanzania: A Point Prevalence Study
Viveka Nordberg, Sweden
563
Serum calprotectin as a routine biochemical parameter to improve early diagnosis of neonatal infections
Sabrina Holzapfel, Germany
124
Implementation of Pooled Saliva Tests for Universal Screening of Congenital Cytomegalovirus (cCMV) Infection: Lessons Derived Over a 25-Months Period
Smadar Eventov-Friedman, Israel
528
Concerns of parents of premature infants contributing to vaccine hesitancy: a multi-centre, mixed-methods interview
Arangan Kirubakaran, United Kingdom
777
Neonatal mice with immature nephrogenesis demonstrate increased renal tissue biomarkers of inflammation and kidney injury during acute Escherichia coli sepsis
Esther Speer, United States
496
Serial C-Reactive Protein Point-of-Care testing to optimize antibiotic treatment in children with signs of infection in Zanzibar: A Feasibility Study
Daniel Msesa, Tanzania
673
Management of term and late-preterm neonates with risk factor for EOS according to three different protocols
Carlo Pietrasanta, Italy
21
BACTERIAL PATHOGENS AND ANTIBIOTIC SUSCEPTIBILITY PATTERNS AMONG NEONATES WITH SEPSIS AT KENYATTA NATIONAL HOSPITAL, NEWBORN UNIT.
Florence Murila, Kenya
87
Incidence of delayed vaccination and insufficient antibody-levels against preventable diseases in one year old very preterm infants
Michael Zemlin, Germany
Moderators: Claus Klingenberg, Norway, Varvara Dimopoulou, Switzerland
304
Hexavalent vaccination in preterm infants: Deviations from the recommended 3+1 vaccination schedule in one year old very preterm infants
Michael Zemlin, Germany
113
Neonatal methylation-based predictors of cognition at 2 and 5 years of age
Rebekah Smikle, United Kingdom
347
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Breastfeeding: The Prospective, Multicentre, Open-Label, Phase IV SOPRANINO Study
Carlo Pietrasanta, Italy
656
A NOVEL ASSOCIATION BETWEEN MATERNAL HLA/HNA ANTIBODIES AND NEONATAL RESPIRATORY DISTRESS
Kajsa Bohlin, Sweden
94
Emergence of Carbapenem-Resistant Enterobacteriaceae (CPE) and Other Multidrug-Resistant Gram-Negative Bacteria in Neonates at a Tertiary-Level NICU in Tanzania: A Point Prevalence Study
Viveka Nordberg, Sweden
563
Serum calprotectin as a routine biochemical parameter to improve early diagnosis of neonatal infections
Sabrina Holzapfel, Germany
124
Implementation of Pooled Saliva Tests for Universal Screening of Congenital Cytomegalovirus (cCMV) Infection: Lessons Derived Over a 25-Months Period
Smadar Eventov-Friedman, Israel
528
Concerns of parents of premature infants contributing to vaccine hesitancy: a multi-centre, mixed-methods interview
Arangan Kirubakaran, United Kingdom
777
Neonatal mice with immature nephrogenesis demonstrate increased renal tissue biomarkers of inflammation and kidney injury during acute Escherichia coli sepsis
Esther Speer, United States
496
Serial C-Reactive Protein Point-of-Care testing to optimize antibiotic treatment in children with signs of infection in Zanzibar: A Feasibility Study
Daniel Msesa, Tanzania
673
Management of term and late-preterm neonates with risk factor for EOS according to three different protocols
Carlo Pietrasanta, Italy
21
BACTERIAL PATHOGENS AND ANTIBIOTIC SUSCEPTIBILITY PATTERNS AMONG NEONATES WITH SEPSIS AT KENYATTA NATIONAL HOSPITAL, NEWBORN UNIT.
Florence Murila, Kenya
87
Incidence of delayed vaccination and insufficient antibody-levels against preventable diseases in one year old very preterm infants
Michael Zemlin, Germany
Speaker
Prof. Kajsa Bohlin
Doctor
Karolinska Institutet
A NOVEL ASSOCIATION BETWEEN MATERNAL HLA/HNA ANTIBODIES AND NEONATAL RESPIRATORY DISTRESS
Prof. Smadar Eventov-Friedman
Physician
Hadassah Medical Organization
Implementation of Pooled Saliva Tests for Universal Screening of Congenital Cytomegalovirus (cCMV) Infection: Lessons Derived Over a 25-Months Period
Dr. Arangan Kirubakaran
Doctor
Imperial College Healthcare NHS Trust
Concerns of parents of premature infants contributing to vaccine hesitancy: a multi-centre, mixed-methods interview
Ms. Stine Lund
Doctor
University Hospital of Northern Zealand
Serial C-Reactive Protein Point-of-Care testing to optimize antibiotic treatment in children with signs of infection in Zanzibar: A Feasibility Study
Dr. Holger Michel
Neonatology, Pediatric Cardiology, Pediatric Intensive Care
University Children's Hospital Regensburg (KUNO), Hospital St. Hedwig Of The Order Of St. John, University Of Regensburg
Serum calprotectin as a routine biochemical parameter to improve early diagnosis of neonatal infections
Dr. Florence Murila
Doctor
University Of Nairobi
BACTERIAL PATHOGENS AND ANTIBIOTIC SUSCEPTIBILITY PATTERNS AMONG NEONATES WITH SEPSIS AT KENYATTA NATIONAL HOSPITAL, NEWBORN UNIT.
Dr. Helga Naburi
Physician
Muhimbili University Of Health And Allied Sciences
Emergence of Carbapenem-Resistant Enterobacteriaceae (CPE) and Other Multidrug-Resistant Gram-Negative Bacteria in Neonates at a Tertiary-Level NICU in Tanzania: A Point Prevalence Study
Dr. Carlo Pietrasanta
Researcher
Department of Clinical Sciences and Community Health, University of Milan
B-Cell Levels, Humoral Responses and 1-Year Follow-Up in Infants Potentially Exposed to Ocrelizumab During Breastfeeding: The Prospective, Multicentre, Open-Label, Phase IV SOPRANINO Study
Dr. Carlo Pietrasanta
Researcher
Department of Clinical Sciences and Community Health, University of Milan
Management of term and late-preterm neonates with risk factor for EOS according to three different protocols
Ms. Rebekah Smikle
Student
University Of Edinburgh
Neonatal methylation-based predictors of cognition at 2 and 5 years of age
Dr. Esther Speer
Physician
Stony Brook University
Neonatal mice with immature nephrogenesis demonstrate increased renal tissue biomarkers of inflammation and kidney injury during acute Escherichia coli sepsis
Prof. Michael Zemlin
Researcher
Saarland University Medical Center
Hexavalent vaccination in preterm infants: Deviations from the recommended 3+1 vaccination schedule in one year old very preterm infants
Prof. Michael Zemlin
Researcher
Saarland University Medical Center
Incidence of delayed vaccination and insufficient antibody-levels against preventable diseases in one year old very preterm infants
The Organising Secretariat
Any questions or comments please contact us at info@jenscongress.eu
Follow us to stay updated!
